References:
1 Sharma ST, Nieman LK, Feelders RA. Cushing’s syndrome: epidemiology
and developments in disease management. Clinical epidemiology.
2015;7:281.
2 Buliman A, Tataranu LG, Paun DL, Mirica A, Dumitrache C. Cushing’s
disease: a multidisciplinary overview of the clinical features,
diagnosis, and treatment. Journal of medicine and life. 2016
Jan;9(1):12.
3 Pappachan JM, Hariman C, Edavalath M, Waldron J, Hanna FW. Cushing’s
syndrome: a practical approach to diagnosis and differential diagnoses.
Journal of clinical pathology. 2017 Apr 1;70(4):350-9.
4.Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review
of neuroendocrine tumors and carcinomas. Neoplasia. 2017 Dec
1;19(12):991-1002.
5 Filosso PL, Ruffini E, Solidoro P, Roffinella M, Lausi PO, Lyberis P,
Oliaro A, Guerrera F. Neuroendocrine tumors of the thymus. Journal of
thoracic disease. 2017 Nov;9(Suppl 15):S1484.
6 Rosai J, Higa E. Mediastinal endocrine neoplasm, of probable thymic
origin, related to carcinoid tumor. Clinicopathologic study of 8 cases.
Cancer. 1972 Apr;29(4):1061-74.
7 Lawrence L, Zhang P, Choi H, Ahmad U, Arrossi V, Purysko A, Makin V. A
unique case of ectopic Cushing’s syndrome from a thymic neuroendocrine
carcinoma. Endocrinology, diabetes & metabolism case reports. 2019 Feb
22;2019(1).
8 Chaer R, Massad MG, Evans A, Snow NJ, Geha AS. Primary neuroendocrine
tumors of the thymus. The Annals of thoracic surgery. 2002 Nov
1;74(5):1733-40.
Figures legends:
figure 1: axial contrast-enhanced CT Study at the level of mid-thoracic
regions shows a small peripherally enhancing solid abnormality within
the thymus (Circle
figure 2: Axial contrast-enhanced CT study at the level of the upper
abdomen shows a smooth enlargement of both adrenal glands in keeping
with hypertrophy ( arrows)